Carfilzomib + Lenalidomide and Dexamethasone for BTK Inhibitors Relapsed-refractory or Intolerant MCL
Clinical trial NCT03891355 · UNKNOWN
Trial details
- NCT number
- NCT03891355
- Sponsor
- Fondazione Italiana Linfomi - ETS
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-30
- Primary completion
- 2020-12-04
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.